22 Apr 2015
Crossing Biological Barriers – International conference – save the date
Crossing Biological Barriers – Advances in Nanocarrier Design for Targeted Drug Delivery, 9-11 November 2015, Dresden, Germany

About Alexander


The ALEXANDER project aims at the identification of novel strategies (e.g., proteolytic enzyme strategy, thiomer strategy, zeta potential changing systems, SNEDDS strategy) and the optimization of existing strategies (e.g., disulphide breaking strategy and slippery surface strategy) for the efficient transport of nanocarriers through the mucus gel layer (e.g., intestinal, ocular).

In particular, R&D activities will be focused on the synthesis of functionalized nanocarriers capable of permeating the mucus gel layer and delivering their therapeutic payload to the epithelium.


ALEXANDER structure

Work within in ALEXANDER is organized in seven workpackages (WPs). The chart below shows the interrelation between the WPs.



The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 280761